Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide
- PMID: 16953210
- DOI: 10.1038/sj.bmt.1705485
Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide
Abstract
Malignant infantile osteopetrosis (MIOP) is a rare hereditary disorder of osteoclast function, which can be reversed by hematopoietic stem cell transplantation (SCT). We observed a high incidence of hepatic veno-occlusive disease (VOD) in transplanted patients and explored the prevention of this complication by using defibrotide (DF) as a prophylaxis. Twenty children with MIOP were consecutively transplanted in our center between 1996 and 2005. Eleven of these patients were transplanted between 1996 and 2001 and experienced an overall incidence of VOD of 63.6% (7/11). VOD was severe in three patients and one patient succumbed to VOD-related multi-organ failure. Owing to this very high incidence of VOD, DF prophylaxis was initiated in nine patients consecutively transplanted between 2001 and 2005. In this group, only one patient (11.1%) was diagnosed with moderate VOD. We report here a very high risk in patients with MIOP to develop VOD after transplantation. Prophylactic DF was implemented in our current transplant protocol and reduced the VOD rate significantly in this high-risk population.
Similar articles
-
Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.Pediatr Blood Cancer. 2008 Apr;50(4):831-2. doi: 10.1002/pbc.21425. Pediatr Blood Cancer. 2008. PMID: 18286502
-
Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy.Haematologica. 2006 Jun;91(6):795-800. Haematologica. 2006. PMID: 16769582 Clinical Trial.
-
Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.Expert Rev Hematol. 2012 Jun;5(3):291-302. doi: 10.1586/ehm.12.18. Expert Rev Hematol. 2012. PMID: 22780209 Review.
-
BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.Br J Haematol. 2013 Nov;163(4):444-57. doi: 10.1111/bjh.12558. Epub 2013 Sep 17. Br J Haematol. 2013. PMID: 24102514
-
Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: review and update on the use of defibrotide.Semin Thromb Hemost. 2007 Jun;33(4):373-88. doi: 10.1055/s-2007-976173. Semin Thromb Hemost. 2007. PMID: 17525895 Review.
Cited by
-
Case report: Gene mutations and clinical characteristics of four patients with osteopetrosis.Front Pediatr. 2023 Mar 14;11:1096770. doi: 10.3389/fped.2023.1096770. eCollection 2023. Front Pediatr. 2023. PMID: 36999084 Free PMC article.
-
Genetic testing confirmed osteopetrosis with initial presentation of nystagmus.Taiwan J Ophthalmol. 2023 Apr 28;14(3):437-440. doi: 10.4103/tjo.TJO-D-22-00152. eCollection 2024 Jul-Sep. Taiwan J Ophthalmol. 2023. PMID: 39430360 Free PMC article.
-
[Chinese expert consensus on the diagnosis and management of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (2022)].Zhonghua Xue Ye Xue Za Zhi. 2022 Mar 14;43(3):177-183. doi: 10.3760/cma.j.issn.0253-2727.2022.03.001. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35405774 Free PMC article. Chinese. No abstract available.
-
Osteopetrosis: genetics, treatment and new insights into osteoclast function.Nat Rev Endocrinol. 2013 Sep;9(9):522-36. doi: 10.1038/nrendo.2013.137. Epub 2013 Jul 23. Nat Rev Endocrinol. 2013. PMID: 23877423 Review.
-
Stem cell transplantation for osteopetrosis in patients beyond the age of 5 years.Blood Adv. 2019 Mar 26;3(6):862-868. doi: 10.1182/bloodadvances.2018025890. Blood Adv. 2019. PMID: 30885997 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous